SCH-900237

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NameSCH-900237
Drug Alias Name屋尘螨过敏原提取物HDM AITALK HDMHouse dust mite allergy immunotherapyHouse dust mite allergen extract +[23] 
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAllergic asthmaHypersensitivityConjunctivitis, Allergic +[7] 
Global Approved IndicationsRhinitis, Allergic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryMainland China(BOAO LECHENG)CzechiaBulgaria +[21] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAlk-Abello Sa
China Registration ClassN/A

Develop Information

Active CompaniesAlk-Abello SaAlk-Abelló A/STorii Pharmaceutical Co Ltd +[4] 
Inactive CompaniesAbbott LaboratoriesUniversity Of SouthamptonEmory University +[6] 
Active IndicationsAllergic asthmaConjunctivitis, AllergicRhinitis, Allergic +[4] 
Inactive IndicationsHypersensitivityRhinitis, Allergic, PerennialRhinitis

Other Information

ATC CodeV01AA03
Related LinksN/A